Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SILDENAFIL | 50MG | TABLET | Resolved | 2020-10-28 | 2020-12-07 | 127373 |
APO-CETIRIZINE | 10MG | TABLET | Resolved | 2020-12-04 | 2020-12-11 | 129598 |
APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-11-26 | 2020-12-17 | 128933 |
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2020-09-09 | 2020-12-17 | 123957 |
APO-OLANZAPINE | 10.0MG | TABLET | Resolved | 2020-10-07 | 2020-12-17 | 125815 |
APO-OLANZAPINE | 15.0MG | TABLET | Resolved | 2020-06-24 | 2020-12-17 | 118769 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2020-07-29 | 2020-12-17 | 121334 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2020-07-29 | 2020-12-17 | 121337 |
APO-QUETIAPINE | 100MG | TABLET | Resolved | 2020-11-19 | 2020-12-17 | 128618 |
APO-CINACALCET | 30MG | TABLET | Resolved | 2020-10-14 | 2020-12-21 | 126274 |
APO-CINACALCET | 60MG | TABLET | Resolved | 2020-10-28 | 2020-12-21 | 127331 |
APO-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-04-13 | 2020-12-21 | 111931 |
APO-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-04-13 | 2020-12-21 | 111928 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-11-04 | 2020-12-21 | 127759 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-11-19 | 2020-12-21 | 128621 |
APO-RAMIPRIL | 15MG | CAPSULE | Resolved | 2020-09-22 | 2020-12-21 | 124798 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-10-28 | 2020-12-21 | 127370 |
APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2020-11-19 | 2020-12-28 | 128612 |
APO-WARFARIN | 5MG | TABLET | Resolved | 2020-10-21 | 2020-12-28 | 126780 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2020-11-19 | 2020-12-28 | 128629 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
APO-DILTIAZ TZ | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1072 |
APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |
APO-DILTIAZ TZ | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1078 |
APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
APO-PROPRANOLOL | 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1163 |
APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |